Johnson & Johnson (NYSE:JNJ)

166.86
Delayed Data
As of 4:00pm ET
 -0.72 / -0.43%
Today’s Change
155.72
Today|||52-Week Range
186.69
-2.46%
Year-to-Date
JNJ Regular Dividend: JNJ will begin trading ex-dividend on 08/22/22 with a $1.13 dividend payable to shareholders of record as of 08/23/22.
Why Is Johnson & Johnson (JNJ) Down 1.8% Since Last Earnings Report?
11:30am / Zacks.com - Paid Partner Content
AstraZeneca's (AZN) Lynparza sNDA Gets FDA Priority Tag
Aug 16 / Zacks.com - Paid Partner Content
1 Stock You Shouldn't Sell No Matter What
10:35am / StockNews.com - Paid Partner Content
1 Stock Warren Buffett Might Have Sold Too Soon
Aug 16 / StockNews.com - Paid Partner Content
AbbVie (ABBV) Outperforms Industry This Year So Far: Here's Why
8:40am / Zacks.com - Paid Partner Content
These 6 Dividend Stocks Pay $83 Billion a Year, Combined, to Their Shareholders
Aug 16 / MotleyFool.com - Paid Partner Content
2 Pharma Stocks That'll Make You Rich in the Long Term
Aug 16 / StockNews.com - Paid Partner Content
Top 5 2nd Quarter Trades of Hotaling Investment Management, LLC
Aug 15 / GuruFocus News - Paid Partner Content
Here is What to Know Beyond Why Johnson & Johnson (JNJ) is a Trending Stock
Aug 16 / Zacks.com - Paid Partner Content
Top 5 2nd Quarter Trades of Evercore Wealth Management, LLC
Aug 15 / GuruFocus News - Paid Partner Content

Today’s Trading

Previous close167.58
Today’s open167.97
Day’s range165.93 - 168.20
Volume8,312,105
Average volume (3 months)7,161,680
Market cap$434.6B
Data as of 4:00pm ET, 08/18/2022

Growth & Valuation

Earnings growth (last year)+41.93%
Earnings growth (this year)+3.06%
Earnings growth (next 5 years)+5.00%
Revenue growth (last year)+13.55%
P/E ratio24.3
Price/Sales4.88
Price/Book5.87

Competitors

 Today’s
change
Today’s
% change
LLYEli Lilly and Co+0.13+0.04%
PFEPfizer-0.68-1.38%
ABBVAbbVie-0.06-0.04%
MRKMerck+0.36+0.40%
Data as of 4:00pm ET, 08/18/2022

Financials

Next reporting dateOctober 18, 2022
EPS forecast (this quarter)$2.53
Annual revenue (last year)$93.8B
Annual profit (last year)$20.9B
Net profit margin22.27%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
No executives to display
Corporate headquarters
New Brunswick, New Jersey

Forecasts